Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: jerryriti who wrote (877)	7/11/1999 6:43:00 PM
From: Doug (Htfd,CT)	Read Replies (2) \| Respond to of 1728

The "sympathy" buying theory is supported by MLNM jump on Friday. It may be that individuals looking for replacements for the Web stock blow-off of April are jumping on genomics. I plan to review my lists of other genome-involved issues for others about to break out of sound basing patterns. I've been very pleased by AFFX's move ... up around 50% in just a few weeks, coming off of a big, beautiful base. When I heard the HGSI story Thursday, I stated it to my wife and daughter: "HGSI announced finding a gene that might turbo-boost the human immune system." My twelve year old immediately brightened and said "A cure for AIDS!" Well, we know its WAY too early to say that, but I expect that many beginning investors will have the same reaction and start looking for other "gene technology" stocks ... and AFFX might be seen to be the Intel of the group ... selling the core functions for all the others to progress. The sector may be about to get its innings, as the most recent ASAP issue predicted. Doug (long AFFX and HGSI, watching for MLNM on softness Monday)